Longitudinal pharmacokinetic and pharmacodynamic study in first and third trimester of pregnancy
This will be a longitudinal addition to an existing R21cohort enrolled in the first trimester to include a first and third trimester assessment of pharmacokinetics/pharmacodynamics (PK/PD) of aspirin and how individual factors impact aspirin PK/PD in pregnancy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
20
one tab daily
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
salicylic acid level
time/concentration profile
Time frame: 24 hour
serum thromboxane
ELISA based quantification of serum thromboxane B2
Time frame: 4 week post initiation
PFA-100
PFA-100 epi closure time (Siemens)
Time frame: 4 week post initiation
Urinary thromboxane
ELISA based quantification of urindary dehydrothromboxane B2
Time frame: 4 week post initiation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.